Infection Probability Score: a predictor of Clostridium difficile-associated disease onset in patients with haematological malignancy

Eur J Oncol Nurs. 2011 Dec;15(5):404-9. doi: 10.1016/j.ejon.2010.11.002. Epub 2010 Dec 3.

Abstract

Purpose: to assess the predictive power of three systems: Infection Probability Score, APACHE II and KARNOFSKY score for the onset of Clostridium difficile-associated disease (CDAD) in hematology-oncology patients.

Methods and sample: A retrospective pilot surveillance survey was conducted in the hematology unit of a general hospital in Greece. Data were collected by using an anonymous standardised case-record form. The sample consisted of 102 hospitalized patients.

Results: The majority of the patients (33.3%) suffered from acute myeloid leukemia. The cumulative incidence of CDAD was 10.8% and the incidence rate of C difficile associated diarrhea was 5 per 1000 patient-days (14.2 per 1000 patient-days at risk). Patients with CDAD had twofold higher time of mean length of hospital stay compared with patients without CDAD (38.82 ± 23.88 vs 19.45 ± 14.56 days). Additionally patients with CDAD had received a greater number of different antibiotics compared to those without CDAD (5.18 ± 1.99 vs 2.54 ± 2.13), suffered from diabetes, from non Hodgkin's lymphoma, had a statistically significant higher duration of neutropenia ≥3 days and had received antifungal treatment. The best cutoff value of IPS for the prediction of CDAD was 13 with a sensitivity of 45.5% and a specificity of 82.4%.

Conclusions: IPS is an early diagnostic test for CDAD detection.

Publication types

  • Comparative Study

MeSH terms

  • APACHE
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Clostridioides difficile*
  • Cross Infection / diagnosis*
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Enterocolitis, Pseudomembranous / diagnosis*
  • Enterocolitis, Pseudomembranous / epidemiology
  • Female
  • Greece / epidemiology
  • Hematologic Neoplasms / complications*
  • Humans
  • Incidence
  • Karnofsky Performance Status
  • Male
  • Middle Aged
  • Pilot Projects
  • Population Surveillance / methods*
  • Predictive Value of Tests
  • Probability
  • Retrospective Studies
  • Sensitivity and Specificity
  • Young Adult